DK1161256T3 - Anvendelse af nervevækstfaktor til fremstilling af et medikament til terapi af intraokulære vævspatologier - Google Patents

Anvendelse af nervevækstfaktor til fremstilling af et medikament til terapi af intraokulære vævspatologier

Info

Publication number
DK1161256T3
DK1161256T3 DK00901331T DK00901331T DK1161256T3 DK 1161256 T3 DK1161256 T3 DK 1161256T3 DK 00901331 T DK00901331 T DK 00901331T DK 00901331 T DK00901331 T DK 00901331T DK 1161256 T3 DK1161256 T3 DK 1161256T3
Authority
DK
Denmark
Prior art keywords
therapy
growth factor
nerve growth
drug
manufacture
Prior art date
Application number
DK00901331T
Other languages
Danish (da)
English (en)
Inventor
Alessandro Lambiase
Original Assignee
Anabasis S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anabasis S R L filed Critical Anabasis S R L
Application granted granted Critical
Publication of DK1161256T3 publication Critical patent/DK1161256T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00901331T 1999-01-29 2000-01-21 Anvendelse af nervevækstfaktor til fremstilling af et medikament til terapi af intraokulære vævspatologier DK1161256T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000069A IT1305294B1 (it) 1999-01-29 1999-01-29 Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.

Publications (1)

Publication Number Publication Date
DK1161256T3 true DK1161256T3 (da) 2006-09-18

Family

ID=11406408

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00901331T DK1161256T3 (da) 1999-01-29 2000-01-21 Anvendelse af nervevækstfaktor til fremstilling af et medikament til terapi af intraokulære vævspatologier

Country Status (11)

Country Link
US (3) US9468665B1 (fr)
EP (1) EP1161256B1 (fr)
AT (1) ATE325618T1 (fr)
AU (1) AU2129200A (fr)
CY (1) CY1106140T1 (fr)
DE (1) DE60027878T2 (fr)
DK (1) DK1161256T3 (fr)
ES (1) ES2264416T3 (fr)
IT (1) IT1305294B1 (fr)
PT (1) PT1161256E (fr)
WO (1) WO2000044396A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1305294B1 (it) * 1999-01-29 2001-05-04 Alessandro Lambiase Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.
EP1589988A2 (fr) 2002-12-20 2005-11-02 Neuronicon ApS Modulation de l'activite de neurotrophines
ITRM20050447A1 (it) * 2005-08-19 2007-02-20 Anabasis S R L Uso del nerve growth factor in collirio nella terapia di patologie del sistema nervoso centrale, quali la malattia di alzheimer e il morbo di parkinson.
EP3225251B1 (fr) 2006-12-21 2020-02-12 H. Lundbeck A/S Modulation de l'activité des proneurotrophines
IT1396607B1 (it) 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
IT202000032423A1 (it) 2020-12-24 2022-06-24 Univ Degli Studi Di Trieste Metodo per la produzione di forme processate proteoliticamente di fattori trofici o fattori di crescita

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE382477C (de) 1923-10-03 Willy Pietzsch Vorrichtung zum Versenken von Schreibmaschinen in Schreibmaschinentischen, bei der die Schreibmaschine in wagerechter Lage nach einem seitlich in anderer Hoehenlage befindlichen Standplatz auf und ab bewegt wird
US4959319A (en) 1985-08-01 1990-09-25 Skelnik Debra L Process of corneal enhancement
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US4973466A (en) * 1988-06-21 1990-11-27 Chiron Ophthalmics, Inc. Wound-healing dressings and methods
DE3827477A1 (de) 1988-08-12 1990-02-22 Biotechnolog Forschung Gmbh Verfahren zur isolierung und zur alleinigen zuechtung von endothelialzellen der menschlichen hornhaut (hcec)
US5260059A (en) 1989-04-14 1993-11-09 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor
US5667968A (en) * 1989-08-30 1997-09-16 Regeneron Pharmaceuticals, Inc. Prevention of retinal injury and degeneration by specific factors
US5641479A (en) 1991-02-12 1997-06-24 Richardson-Vicks Inc. Cosmetic compositions comprising an imidazolium derivative and branched polyethylene glycol
US5272135A (en) 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
IT1255657B (it) 1992-05-29 1995-11-09 Colture di tessuto di mucosa congiuntivale differenziata, procedimentoper la loro preparazione e supporti per il loro uso.
US5767079A (en) * 1992-07-08 1998-06-16 Celtrix Pharmaceuticals, Inc. Method of treating ophthalmic disorders using TGF -β
US5641749A (en) * 1995-11-29 1997-06-24 Amgen Inc. Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
US6063757A (en) * 1995-11-29 2000-05-16 Urso; Richard G. Wound treatment method with nerve growth factor
US5641750A (en) * 1995-11-29 1997-06-24 Amgen Inc. Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US6299895B1 (en) * 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
BR9712824A (pt) 1996-09-13 1999-12-21 Advanced Medicine Research Ins Composição oftálmica de fator neurotrófico, agente de tratamento de desordem funcional do nervo ótico e método para tratamento de desordem funcional do nervo ótico
JPH10218787A (ja) * 1997-02-06 1998-08-18 Akio Okamoto 神経栄養因子による眼科用組成物
IT1291892B1 (it) * 1997-04-24 1999-01-21 Alessandro Lambiase Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella
AU8559398A (en) 1998-08-05 2000-02-28 Advanced Medicine Research Institute Remedies for cerebral central lesions with the use of neurotrophic factors
DE69923998T2 (de) 1998-12-09 2006-04-27 Chiron Corp., Emeryville Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems
IT1305294B1 (it) * 1999-01-29 2001-05-04 Alessandro Lambiase Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.
US20020009498A1 (en) 1999-11-05 2002-01-24 Guy L. Clifton Methods and compositions for treatment of traumatic brain injury
IL147921A0 (en) 2002-01-31 2002-08-14 Abdulrazik Mohammad A method for treating central nervous system disorders by ocular dosing

Also Published As

Publication number Publication date
ITRM990069A1 (it) 2000-07-29
US10010586B2 (en) 2018-07-03
DE60027878D1 (de) 2006-06-14
US9345749B2 (en) 2016-05-24
US20170007670A1 (en) 2017-01-12
EP1161256A1 (fr) 2001-12-12
PT1161256E (pt) 2006-09-29
AU2129200A (en) 2000-08-18
IT1305294B1 (it) 2001-05-04
US20120142591A1 (en) 2012-06-07
ES2264416T3 (es) 2007-01-01
CY1106140T1 (el) 2011-06-08
US9468665B1 (en) 2016-10-18
ATE325618T1 (de) 2006-06-15
DE60027878T2 (de) 2007-04-19
EP1161256B1 (fr) 2006-05-10
WO2000044396A1 (fr) 2000-08-03

Similar Documents

Publication Publication Date Title
AU767163B2 (en) Methods for restoring and/or enhancing accommodation in pseudo phakia
ES2207963T3 (es) Antagonistas muscarinicos en el tratamiento de presbiopia.
EA200501018A1 (ru) Офтальмологический препарат для профилактики и лечения болезненных состояний глаз
US20020161013A1 (en) Method of local anesthesia and analgesia
CY1106140T1 (el) Χρηση νευρικου αυξητικου παραγοντα για την παρασκευη ενος φαρμακου για την θepαπεια παθολογικων καταστασεων του ενδοφθαλμικου ιστου
Murray et al. Collagen shield heparin delivery for prevention of postoperative fibrin
RU2014151992A (ru) Лечение воспалительных заболеваний глаз с применением лахинимода
KR102256185B1 (ko) 멜라닌 및 멜라닌 유사체, 전구체, 및 유도체로 안과 질병, 질환, 및 증상의 치료 및 예방을 위한 방법
AU2014382677A1 (en) Pharmacological ophthalmic composition for use in the correction of presbyopia and its administration
CN105188702A (zh) 使用双嘧达莫的用于治疗眼睛疾病的组合物
RU2008107696A (ru) Неинвазивная система доставки лекарственного средства к ткани заднего сегмента глаза с применением твердой композиции
WO2014142469A2 (fr) Composition de gouttes ophtalmiques pour le traitement d'une maladie inflammatoire oculaire et son procédé de préparation
DE69028877D1 (de) Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden
IT9020968A1 (it) Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche
ATE251905T1 (de) Verwendung von ubiquinon q 10 zur vorbeugung und behandlung von postoperativen okularen pathologien
RU2607291C1 (ru) Способ лечения первичной глаукомы у больных с сопутствующей артериальной гипертензией
ES2234428B1 (es) Compuestos para el tratamiento de la sequedad de la superficie ocular provocada por la cirugia fotorrefractiva.
RU2104678C1 (ru) Способ лечения заболеваний глаза
RU2402303C1 (ru) Способ лечения врастания эпителия
Bellucci Topical anaesthesia for small incision cataract surgery
Crawford Cortisone in glaucoma secondary to uveitis
Bhartiya Pilocarpine: The Renaissance
Ara et al. Occular Drug Delivery System: An Overview
RU2117466C1 (ru) Способ профилактики и лечения глазных заболеваний
US20060058345A1 (en) Use of papaverine-like vasodilator and pharmaceutical composition